Anbio Biotechnology: stockholders_equity
| Value | {"amount": 17191550, "concept": "us-gaap:StockholdersEquity", "currency": "USD"} |
|---|---|
| Period | (as of 2024-12-31) |
| Status | current |
| Entity | Anbio Biotechnology |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T19:02:33.643442+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/23430f51-a4f4-4bac-975d-0af27bd3b40f
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001213900-25-035802Retrieved: 2026-08-19T19:02:33.643442+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001982708/stockholders-equity/2024-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/23430f51-a4f4-4bac-975d-0af27bd3b40f
History
- no predecessors — first report